Onconic Therapeutics Calls Extraordinary Shareholder Meeting
Onconic Therapeutics will hold an extraordinary shareholders meeting on Nov. 26, 2026, at 9 a.m. in Seoul. Shareholders will vote on expanding the board and appointing independent directors and audit committee members for three-year terms. Lee Kyung-min’s appointments require Public Service Ethics Committee employment